REFERENCES
- Helderman HJ. Principles and practices of renal trans-plant rejection. In: Jacobson HR, Striker GE, Klahr S, editors. The principles and practice of nephrology. USA: Mosby Yearbook, 1995: 811–21.
- Graffenried B, Harrison WB. Ciclosporin in autoimmune diseases—side effects (with emphasis on renal dysfunc-tion) and recommendations for use. In: Schindler R, editor. Ciclosporin in autoimmune diseases. Berlin: Springer-Verlag, 1985: 59–73.
- Kone BC, Whelton A, Santos G, Saral R. Hypertension and renal dysfunction in bone marrow transplant recipients. Q J Med 1988; 69: 985–95.
- Sutton RAL, Sakhaee K. Hypomagnesemia. In: Jacobson HR, Striker GE, Klahr S, editors. The principles and practice of nephrology. USA: Mosby Yearbook, 1995: 1008–12.
- Cogan GM. Fluid and electrolytes. USA: Appleton & Lange, 1991: 283–91.
- Kim HJ, Alm YH, Kee CS, Lee KS, Kwak JY. Early short-term profile of serum magnesium concentration in living donor renal transplant recipients on cyclosporine. Transplant Proc 1994; 26(4): 2178–80.
- Tapal MF. Colchicine myopathy. Scand J Rheumatol 1996; 25(2): 105–6.